Display options
Share it on

Transl Oncol. 2019 Jan;12(1):134-142. doi: 10.1016/j.tranon.2018.09.001. Epub 2018 Oct 05.

The Evolutionarily Conserved Cassette Exon 7b Drives ERG's Oncogenic Properties.

Translational oncology

Samantha L Jumbe, Sean R Porazinski, Sebastian Oltean, Jason P Mansell, Bahareh Vahabi, Ian D Wilson, Michael R Ladomery

Affiliations

  1. Faculty of Health and Applied Sciences, University of the West of England, Coldharbour Lane, Frenchay, Bristol BS16 1QY, United Kingdom.
  2. Institute of Biomedical & Clinical Sciences, University of Exeter Medical School, St Luke's Campus, Heavitree Rd, Exeter, EX1 2LU, United Kingdom.
  3. Faculty of Health and Applied Sciences, University of the West of England, Coldharbour Lane, Frenchay, Bristol BS16 1QY, United Kingdom. Electronic address: [email protected].

PMID: 30296658 PMCID: PMC6174920 DOI: 10.1016/j.tranon.2018.09.001

Abstract

The oncogene ERG encodes an ETS family transcription factor and is implicated in blood, vascular, and bone development and in prostate, blood, and bone cancer. The ERG gene is alternatively spliced; of particular interest is its cassette exon 7b which adds 24 amino acids, in frame, to the transcriptional activation domain. Higher exon 7b inclusion rates are associated with increased cell proliferation and advanced prostate cancer. The 24 amino acids encoded by exon 7b show evolutionary conservation from humans to echinoderms, highlighting their functional importance. Throughout evolution, these 24 amino acids are encoded by a distinct short exon. Splice-switching oligonucleotides based on morpholino chemistry were designed to induce skipping of ERG exon 7b in MG63 osteosarcoma and VCaP prostate cancer cells. Induction of exon 7b skipping reduced cell proliferation and invasion, increased apoptosis in vitro, and reduced xenograft growth in vivo. We also show that ERG's exon 7b is required for the induction of tissue nonspecific alkaline phosphatase. Together, these findings show that the evolutionarily conserved cassette exon 7b is central to ERG's oncogenic properties.

Crown Copyright © 2018. Published by Elsevier Inc. All rights reserved.

References

  1. Prostaglandins Other Lipid Mediat. 2006 Jul;80(1-2):46-61 - PubMed
  2. Development. 2017 Jul 1;144(13):2428-2444 - PubMed
  3. Biochem Biophys Res Commun. 2018 Jan 1;495(1):179-184 - PubMed
  4. Cell Commun Signal. 2015 Feb 19;13:12 - PubMed
  5. Genes Dev. 1999 Jan 15;13(2):163-75 - PubMed
  6. J Biol Chem. 2008 Jul 11;283(28):19511-20 - PubMed
  7. Ann N Y Acad Sci. 2010 Mar;1192:190-200 - PubMed
  8. Mol Cancer Ther. 2007 Oct;6(10):2609-17 - PubMed
  9. Cancer Res. 2008 Oct 15;68(20):8516-24 - PubMed
  10. Science. 1987 Aug 7;237(4815):635-9 - PubMed
  11. Dev Biol. 2007 May 1;305(1):40-51 - PubMed
  12. Bone. 2012 Mar;50(3):756-62 - PubMed
  13. J Biol Chem. 1988 Aug 25;263(24):12002-10 - PubMed
  14. Osteoarthritis Cartilage. 2001;9 Suppl A:S41-7 - PubMed
  15. Steroids. 2014 May;83:52-61 - PubMed
  16. J Cell Biol. 2000 Jul 10;150(1):27-40 - PubMed
  17. Oncogene. 2016 Jan 28;35(4):403-14 - PubMed
  18. Clin Chem. 2009 Apr;55(4):611-22 - PubMed
  19. Int Orthop. 2012 Oct;36(10):2181-7 - PubMed
  20. Oncotarget. 2016 Aug 9;7(32):51375-51392 - PubMed
  21. PLoS One. 2013;8(3):e49721 - PubMed
  22. Biochem Biophys Res Commun. 1990 May 16;168(3):993-1000 - PubMed
  23. Biochim Biophys Acta. 2013 Jan;1831(1):105-8 - PubMed
  24. Mol Cell Endocrinol. 2004 May 31;220(1-2):9-20 - PubMed
  25. Am J Clin Pathol. 2014 Oct;142(4):533-40 - PubMed
  26. Gene. 2004 Jan 7;324:65-77 - PubMed
  27. J Biol Chem. 1992 Oct 25;267(30):21360-7 - PubMed
  28. Nucleic Acids Res. 1990 Feb 25;18(4):957-61 - PubMed
  29. J Bone Miner Res. 2011 Feb;26(2):229-38 - PubMed
  30. Biochimie. 2016 Sep-Oct;128-129:193-200 - PubMed

Publication Types